Advertisement
U.S. markets closed
  • S&P Futures

    5,304.25
    -4.00 (-0.08%)
     
  • Dow Futures

    40,140.00
    -36.00 (-0.09%)
     
  • Nasdaq Futures

    18,465.00
    -38.75 (-0.21%)
     
  • Russell 2000 Futures

    2,145.20
    +6.80 (+0.32%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0782
    -0.0012 (-0.11%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • Vix

    13.01
    +0.23 (+1.80%)
     
  • GBP/USD

    1.2622
    +0.0000 (+0.00%)
     
  • USD/JPY

    151.2740
    -0.0980 (-0.06%)
     
  • Bitcoin USD

    70,758.99
    +1,309.02 (+1.88%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,402.22
    +234.15 (+0.58%)
     

Top vaccine makers Merck and Pfizer target China and older adults next

Top vaccine makers Merck and Pfizer target China and older adults next

During the past few decades, the number of companies producing vaccines has dwindled to just a handful. There are other players in the space, but today, the four big drug companies that now dominate the market are Merck MRK , Pfizer PFE , Sanofi Pasteur SAN-FR and GlaxoSmithKline GSK-GB .

Selling a vaccine like Shingrix for the shingles or Gardasil 9 for HPV is where a company can make big profits. Gardasil 9 reached over $3 billion in sales in 2018 and with the patent not expiring until 2028 in the U.S., it could reach billions more, according to analysts.

Watch this video to find out what the future holds for vaccines makers Merck, Pfizer, Sanofi Pasteur and GlaxoSmithKline.

Watch more:

  • What the future holds for Taco Bell after ex-CEO Brian Niccol defected to Chipotle

  • Why Buick does so much better in China than it does in the U.S.




More From CNBC

Advertisement